American International Group’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-35
Closed -$1K 5309
2015
Q4
$1K Buy
+35
New +$387 ﹤0.01% 4997
2014
Q2
Sell
-1,012
Closed -$21.9K 5180
2014
Q1
$21.9K Buy
1,012
+24
+2% +$695 ﹤0.01% 4154
2013
Q4
$34.9K Buy
988
+253
+34% +$8.48K ﹤0.01% 3915
2013
Q3
$26.6K Sell
735
-18
-2% -$820 ﹤0.01% 3979
2013
Q2
$34.1K Buy
+753
New +$34.1K ﹤0.01% 3740

Other funds holding KBIO

American International Group's KBIO Position: Q1 2016 in Review

American International Group sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2016, closing a stake of 35 shares — an estimated $1K sold.

American International Group first reported a position in KBIO in Q2 2013 and held it in 5 quarters. The position peaked at $34.9K in Q4 2013. 1 fund tracked by Wall St. Rank holds KBIO as of Q1 2016.

  • American International Group reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2016 after selling out during the quarter.
  • American International Group sold 35 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2016, an estimated $1K.
  • American International Group first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2013 and held it in 5 quarters.
  • American International Group's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $34.9K in Q4 2013.
  • 1 fund tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2016.

Based on American International Group's 13F filing for Q1 2016, filed 12 May 2016.